My Photo


  • David Foster (shown here with his friend Gracie) is National Strategic Advisor for Morris Communications, and has been a leader within the independent magazine community for years. In April 2005, Dave was diagnosed with Advanced Renal Cell Carcinoma, Stage 4, the sixth deadliest cancer, behind lung, liver, and breast. In emails to his ‘wellness group’ of friends and colleagues, Dave began chronicling his battle with the disease. In this blog, Dave Foster continues to “kick cancer’s arse”, sharing his story with a wider audience.

Contact David

Blog powered by Typepad

« Zowweee-Baby | Main | "Through" Not "To"... »

August 25, 2007



I am with you all the way. If there was some kind of test to detect RCC early it would certainly bring the "numbers" down. I was diagnosed Stage 4 RCC in October, 2003. A large tumor on my left kidney and on my right adrenal gland. It had already spread to my lungs, pancreas, and abdomin. I had NO symptoms. It was a gall bladder attack that triggered the ultrasound that showed it all. I have done IL2, a clinical trial chemo in Bethesda, Maryland, Interferon, a clinical trial at Duke and now Sutent. I read a book once and it referred to our cancer as an 'unpolitically correct' cancer. It doesn't get the attention that others do. I will have to say though, there has been a lot of progress since 2003. All they had to offer then was IL2 with a less than 10% survival rate. Would you believe that when I was diagnosed there wasn't even a 'color' identified. We are now, of course, kelly green. I had to smile when you referred to us as Warriors. I really like that sound and it gave me a very proud feeling. I am a warrior - all of us ARCC survivors are warriors and I will fight this thing, I hope - for many years to come!!!!

Loved the history, the metaphor, the nudge to at least for a moment reflect and remember that our freedom has cost countless a premature and "unfair death", and I like that you are feeling well enough to retell the story. So glad you are feeling better.

The comments to this entry are closed.